| Q34203068 | Combined dynamic contrast-enhanced liver MRI and MRA using interleaved variable density sampling. |
| Q40821441 | Differences in health-related quality of life between European and Asian patients with hepatocellular carcinoma |
| Q36262560 | Electric Ablation with Irreversible Electroporation (IRE) in Vital Hepatic Structures and Follow-up Investigation |
| Q48540046 | International cross-cultural field validation of an European Organization for Research and Treatment of Cancer questionnaire module for patients with primary liver cancer, the European Organization for Research and Treatment of Cancer quality-of-lif |
| Q84135196 | Liver transplantation |
| Q33556420 | Nuclear beta-catenin induces an early liver progenitor phenotype in hepatocellular carcinoma and promotes tumor recurrence |
| Q37231101 | Poorer survival in patients whose explanted hepatocellular carcinoma (HCC) exceeds Milan or UCSF Criteria. An analysis of liver transplantation in HCC in Australia and New Zealand |
| Q34099104 | Rising costs and hospital admissions for hepatocellular carcinoma in Portugal (1993-2005). |
| Q37348887 | Squaring the circle of selection and allocation in liver transplantation for HCC: An adaptive approach. |
| Q46952530 | Total tumor volume is a better marker of tumor burden in hepatocellular carcinoma defined by the Milan criteria |
| Q83423525 | Transarterial chemoembolization for hepatocellular carcinoma |
| Q93184513 | Treatment of hepatocellular carcinoma in patients with portal vein tumor thrombosis: Beyond the known frontiers |
| Q37886890 | What is the best staging system for hepatocellular carcinoma in the setting of liver transplantation? |